What is eosinophilia-mialgia?

Eosinophilia-Mialgia syndrome is the unusual condition first recognized around 1989. This incurable and occasionally fatal condition is considered to be caused by the ingestion of a stained medical supplement called L-Trptophan. It is characterized by symptoms of similar flu, which may include muscle cramps and pain, fever and fatigue, as well as shaking, swelling, hair loss and high eosinophilia.

During the early stages of eosinophilia-milagnia syndrome, it experiences a number of symptoms. The most common symptoms consist of muscles related to muscles such as persistent pain or pain, convulsions and recurring contractions or vibration. Patients may also notice symptoms of flu similar to cough, fever or fatigue, as well as skin diseases such as rashes or itching. This initial period may take from weeks to months, followed by a chronic phase. Some of the most common complications consist of neurocognitive dysfunction such as short -term memory loss, communication problems and troubleE with concentration. Other complications may consist of heart or liver, chronic pain or fatigue, depression or sleep disorders.

Eosinophilia-mix syndrome is said to have been caused by a supplement called L-Tryptophan, essential acid found in sources of plants and animals. This amino acid has long been used in a number of accessories that helps to treat depression, insomnia and premenstrual syndrome. Sometime at the end of the 80s, it is said that a certain Japanese company that began to produce these supplements has issued doses that were either poorly produced or contained genetically modified bacteria that caused eosinophilia-mialgia syndrome in those who consumed them. Although many people who have developed it known that the conditions have taken L-flytophan have never been identified by any specific bacteria.

After first recognized around 1989, it was said that eosinophilia-mialgia syndrome withTal nationwide epidemics in the United States. In the United States alone, about 1,500 cases were reported, 30 of which resulted in death. Cases were also reported in the UK, Germany and Canada. After the initial focus, the administration of food and drugs began to resemble any supplements with the only enita containing L-Testoptofan. Although the number of reported cases has decreased since this withdrawal, many still feel that there is not enough evidence to prove that specific L-Tryptophan supplements are blamed for 1989 epidemic.